期刊文献+

生物医药的安全性及其对策 被引量:2

Safety of biomedicine and it's countermeasures
下载PDF
导出
摘要 生物医药行业是新兴的高科技产业,同时也是一个风险行业,生物医药的安全性问题日益受到人们的重视。在一些生物医药的安全性出现了问题之后,医药界和公众开始认识到,生物医药的安全性十分复杂且不同于传统药物。世界各发达国家均在积极开展生物医药安全方面的研究。本文总结了各种生物医药安全性问题,讨论了重点生物药安全性问题的对策,并就我国的生物医药安全问题提出了对策建议。 Biomedical industry is a new emerging high-tech industry., coupled with risk factors, and more and more attentions have been taken on the safety of biomedicine. After the appearance of some safety issues, both the pharmaceutical industry and the public have begun to realize that the safety of biomedicine is very complex and it is different from traditional medicines. Various developed countries in the world are active in the research on biomedical safety. In this paper, the various security issues in biomedicine have been summarized, the response to the safety of the key biological drug has been discussed and some countermeasures on the safety of biomedicine in our country have been suggested.
出处 《药学实践杂志》 CAS 2009年第5期375-377,共3页 Journal of Pharmaceutical Practice
关键词 生物医药 安全性 biomedicine safety
  • 相关文献

参考文献6

二级参考文献15

  • 1韩慧明,毛建平.siRNA作用效果的靶点依赖性[J].中国生物工程杂志,2004,24(12):6-9. 被引量:5
  • 2王波,陈梅红.反义技术研究进展[J].中国生物工程杂志,2004,24(12):43-47. 被引量:10
  • 3.国药监注[2002]238号.关于进一步加强牛源性及其相关药品监督管理的公告[Z].,2002-07-16.. 被引量:1
  • 4.国药监注[2001]27号.关于禁止药品、生物制品生产中使用疫区牛源性材料的通知[Z].,2001-06-07.. 被引量:1
  • 5.国药管注[2000]489号.关于加强牛源性药品进口管理有关问题的通知[Z].,2000-10-25.. 被引量:1
  • 6BaderF DavisG. DinowitzM etal.医药产品牛海绵状脑病危验的评估 .J Biopharm,1998,11(1):20-31. 被引量:1
  • 7FDA. The sourcing and processing of gelatin to reduce the potential risk posed by bovine spongiform encephalopathy (BSE) in FDA-regulated products for human use [ EB/OL]. http://www. fda. gov, 1997-09-01. 被引量:1
  • 8EMEA/410/01. Note for guidance on minimising the risk of transmitting animal spongiform encephalopathy agents via human and veterinary medicinal products [ EB/OL]. http://www. emea. eu. int, 2004-01 - 18. 被引量:1
  • 9EMEA/40300/00. Explanatory note: gelatin for use in pharmaceuticals[EB/OL]. http://www. emea. eu. int, 2000-12-13. 被引量:1
  • 10IMS HEALTH Global Services.IMS Market Prognosis Asia Report.2003.12.1 被引量:1

共引文献6

同被引文献10

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部